Tomás Herraiz Selected Research

Infections

2/2015

A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomás Herraiz Research Topics

Disease

2	Parkinsonian Disorders (Parkinsonism) 11/2016 - 08/2011
2	Parkinson Disease (Parkinson's Disease) 04/2007 - 11/2006
1	Visceral Leishmaniasis (Kala Azar) 12/2019
1	Mood Disorders (Mood Disorder) 01/2018
1	Infections 02/2015

Drug/Important Bio-Agent (IBA)

4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2016 - 11/2006
4	NeurotoxinsIBA 11/2016 - 11/2006
3	CationsIBA 11/2016 - 04/2007
2	Monoamine Oxidase (MAO)IBA 01/2018 - 08/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 08/2011
2	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 11/2016 - 04/2007
1	triphenylphosphoniumIBA 12/2019
1	BromidesIBA 12/2019
1	SaltsIBA 12/2019
1	AminesIBA 01/2018
1	ImidazolinesIBA 02/2015
1	EnzymesIBA 08/2011
1	2-methyltryptolineIBA 04/2007
1	Carbolines (Beta-Carbolines)IBA 11/2006
1	IsoquinolinesIBA 11/2006